The AI tool predicting child brain cancer relapse represents a groundbreaking advancement in pediatric oncology, offering hope where traditional methods have fallen short.A recent study revealed that this innovative brain cancer prediction tool can accurately assess the risk of relapse in children diagnosed with gliomas, a type of brain tumor.